What is iScreen Vision?
iScreen Vision operates at the intersection of medical technology and pediatric healthcare, specializing in advanced digital vision screening. The company's flagship photoscreening device is engineered to detect vision abnormalities in children as young as one year old, a critical window for preventing permanent vision loss. By simplifying the screening process for medical professionals, iScreen Vision has successfully facilitated over 1.5 million screenings, establishing itself as a vital player in early-intervention diagnostics. The firm's market position is defined by its user-friendly hardware and its ability to integrate seamlessly into existing clinical workflows, ranging from private pediatric practices to school-based health programs.
How much funding has iScreen Vision raised?
iScreen Vision has raised a total of $11M across 5 funding rounds:
Private Equity
$3.3M
Private Equity
$3.5M
Series B
$4M
Debt
$150K
Debt
$160K
Private Equity (2010): $3.3M, investors not publicly disclosed
Private Equity (2013): $3.5M, investors not publicly disclosed
Series B (2013): $4M supported by MB Venture Partners
Debt (2020): $150K featuring PPP
Debt (2021): $160K backed by PPP
Key Investors in iScreen Vision
MB Venture Partners
MB Venture Partners is a Memphis-based venture capital firm that specializes in providing capital and strategic direction to life science companies, particularly in the medical device sector.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for iScreen Vision?
With the support of its latest strategic investment, iScreen Vision is poised to expand its footprint in the digital health market. The company's forward-looking strategy likely involves enhancing its diagnostic algorithms and scaling its distribution network to reach underserved populations. As the demand for efficient, non-invasive pediatric screening tools continues to rise, iScreen Vision is strategically positioned to capitalize on the shift toward preventative care. Future growth will likely focus on deepening clinical partnerships and potentially exploring new diagnostic capabilities, ensuring the company remains at the forefront of pediatric ophthalmology innovation.
See full iScreen Vision company page
